Resveratrol for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis
Background: Inflammatory bowel disease (IBD) is a chronic condition that can be managed with treatment, but it is challenging to get IBD cured. Resveratrol, a non-flavonoid polyphenolic organic compound derived from various plants, has a potential effect on IBD. The current research was set out to i...
Saved in:
Main Authors: | Yuting Gu (Author), Yijie Lou (Author), Zhanyi Zhou (Author), Xuan Zhao (Author), Xiaolu Ye (Author), Shuwen Wu (Author), Haitao Li (Author), Yunxi Ji (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses
by: Xuan He, et al.
Published: (2023) -
The therapeutic efficacy of resveratrol for acute lung injury-A meta−analysis of preclinical trials
by: Yin Tang, et al.
Published: (2022) -
Resveratrol protects against renal ischemia/reperfusion injury: A systematic review and meta-analysis of preclinical studies
by: Li-Hua Wu, et al.
Published: (2022) -
Anti-Autophagy Mechanism of Zhi Gan Prescription Based on Network Pharmacology in Nonalcoholic Steatohepatitis Rats
by: Chufeng Qin, et al.
Published: (2021) -
The Protection Effect of Resveratrol Against Radiation-Induced Inflammatory Bowel Disease via NLRP-3 Inflammasome Repression in Mice
by: Hao Sun, et al.
Published: (2020)